InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Dunne Michael W., Director. Officer active across 1 companies, notably Iterum Therapeutics plc. In total, 4 disclosures have been recorded. The latest transaction was disclosed on 25 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
36,798 shares
Ordinary Shares
SEC:0001209191-22-039312:0·
010,494 shares0
Ordinary Shares
SEC:0001209191-22-021542:0·
080,000 shares0
Ordinary Shares
SEC:0000899243-21-030223·
080,000 shares0
Ordinary Shares
SEC:0000899243-21-030223:0·
4 of 4 declarations
About Dunne Michael W.
Michael W. Dunne is a Board Member at Iterum Therapeutics plc. In this role, he contributes to overseeing the company's activities and shaping its development strategy. Dunne brings significant experience in the biotechnology field, allowing him to guide the company in its research and development initiatives. His commitment to innovation is essential for Iterum's success.
